<DOC>
	<DOC>NCT01992094</DOC>
	<brief_summary>Evaluate safety and immunogenicity of three influenza vaccines in adults 18 years of age and above.</brief_summary>
	<brief_title>Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1. Male or female ages 18 years and older. 2. Individuals who give written informed consent, who can comply with study procedures, and who are available for followup. 1. Individuals recently vaccinated against influenza 2. Subjects with contraindications to receive influenza vaccine 3. Please contact the site for additional eligibility criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Novartis</keyword>
	<keyword>Adults</keyword>
</DOC>